Bausch Health Companies Inc (BHC)

Currency in USD
6.34
+0.13(+2.09%)
Closed·
6.36+0.02(+0.32%)
·

BHC Earnings

Latest Release
Jul 29, 2026
EPS / Forecast
1.26 / 1.03
Revenue / Forecast
2.85B / 2.66B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/1.24--/2.74B----Free Sign Up
2026/061.26/1.032.85B/2.66B+22.33%+7.14%Free Sign Up
2026/030.780/0.6802.52B/2.42B+14.71%+4.13%Free Sign Up
2025/12-0.300/1.212.80B/2.71B-124.79%+3.32%Free Sign Up
2025/090.480/1.042.68B/2.61B-53.85%+2.68%Free Sign Up
2025/060.400/0.0402.53B/2.48B+900%+2.02%Free Sign Up
2025/03-0.160/0.8662.26B/2.29B-118.49%-1.31%Free Sign Up
2024/120.250/0.2302.56B/2.52B+8.7%+1.59%Free Sign Up
2024/09-0.230/1.032.51B/2.42B-122.33%+3.72%Free Sign Up
2024/061.07/0.8762.40B/2.34B+22.15%+2.56%Free Sign Up

All numbers in USD

Bausch Health Companies Inc Earnings Call Summary for Q2/2026

  • Bausch Health Q2 2026 EPS of $1.26 beat estimates by 22.3%; revenue of $2.85B topped forecasts by 7.1%, marking 13th consecutive growth quarter.
  • Company raised FY2026 guidance: revenue to $5.35-5.5B, adjusted EBITDA to $3.025-3.1B, and operating cash flow to $1.4-1.475B amid strong performance.
  • Salix GI unit drove growth with 21% YoY revenue increase; Solta aesthetics segment profit surged 69% following Shibo China integration completion.
  • Net debt reduced by $434M to $13.7B in quarter; management expects H2 headwinds of ~$275M from generic competition and Medicaid channel erosion.
  • Stock rose 6.9% to $4.83 after-hours; management maintained 2027 EBITDA outlook at $2.7B citing pending legal, pricing, and tariff uncertainties.
Last Updated: 2026-07-29, 06:04 p/m
Read Full Transcript

FAQ

What Is Bausch Health's Earnings Per Share (TTM)?

The Bausch Health EPS (TTM) is -2.95.

When Is The Next Bausch Health Earnings Date?

Bausch Health will release its next earnings report on Oct 29, 2026.

What Is Bausch Health’s Revenue Forecasts For Upcoming Quarters?

Bausch Health’s revenue forecast is 2.74B.

How Did Bausch Health React to the Company's Latest Earnings Report?

Bausch Health reported a +22.33% EPS surprise and a +7.14% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by 33.41%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.